Stock EGEPO NASMED ÖZEL SAGLIK HIZMETLERI TICARET ANONIM SIRKETI
Add to a list
To use this feature you must be a member
Log inSign up

Financials Nasmed Özel Saglik Hizmetleri Ticaret Anonim Sirketi

Equities

EGEPO

TRENSMD00029

Healthcare Facilities & Services

Market Closed - Borsa Istanbul
Other stock markets
 11:08:00 2024-05-27 EDT 		5-day change 1st Jan Change
23.92 TRY +3.19% Intraday chart for Nasmed Özel Saglik Hizmetleri Ticaret Anonim Sirketi +10.74% +19.00%
03-21 Nasmed Özel Saglik Hizmetleri Ticaret Anonim Sirketi Reports Earnings Results for the Full Year Ended December 31, 2023 CI
2023 Nasmed Özel Saglik Hizmetleri Ticaret Anonim Sirketi Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI

Valuation

Fiscal Period: December 2021 2022 2023
Capitalization 1 943.8 2,276 2,512
Enterprise Value (EV) 1 932.8 2,312 2,550
P/E ratio 54.1 x 682 x 27.4 x
Yield - - -
Capitalization / Revenue 5.56 x 8.77 x 4.07 x
EV / Revenue 5.49 x 8.9 x 4.13 x
EV / EBITDA 24.2 x 45.7 x 13.7 x
EV / FCF -11,722,512 x -262,885,631 x -229,998,563 x
FCF Yield -0% -0% -0%
Price to Book 3.22 x 7.69 x 2.56 x
Nbr of stocks (in thousands) 125,000 125,000 125,000
Reference price 2 7.550 18.21 20.10
Announcement Date 3/1/22 3/1/23 3/21/24
1TRY in Million2TRY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2020 2021 2022 2023
Net sales 1 114.6 169.8 259.7 617
EBITDA 1 43.49 38.48 50.61 186.8
EBIT 1 36.11 28.52 30.98 111.2
Operating Margin 31.52% 16.8% 11.93% 18.02%
Earnings before Tax (EBT) 1 33.38 18.3 7.689 94.61
Net income 1 32.93 17.44 3.336 91.78
Net margin 28.75% 10.27% 1.28% 14.88%
EPS 2 0.3293 0.1395 0.0267 0.7342
Free Cash Flow - -79.58 -8.793 -11.09
FCF margin - -46.87% -3.39% -1.8%
FCF Conversion (EBITDA) - - - -
FCF Conversion (Net income) - - - -
Dividend per Share - - - -
Announcement Date 3/1/22 3/1/22 3/1/23 3/21/24
1TRY in Million2TRY
Estimates

Balance Sheet Analysis

Fiscal Period: December 2020 2021 2022 2023
Net Debt 1 39.2 - 35.4 37.5
Net Cash position 1 - 10.9 - -
Leverage (Debt/EBITDA) 0.9013 x - 0.6991 x 0.2011 x
Free Cash Flow - -79.6 -8.79 -11.1
ROE (net income / shareholders' equity) - 8.33% 1.13% 9.79%
ROA (Net income/ Total Assets) - 5.89% 4.47% 5.44%
Assets 1 - 296.2 74.62 1,688
Book Value Per Share 2 0.4000 2.350 2.370 7.860
Cash Flow per Share 2 0.0800 0.4900 0.4100 0.4000
Capex 1 28.2 107 56.9 119
Capex / Sales 24.61% 63.21% 21.92% 19.21%
Announcement Date 3/1/22 3/1/22 3/1/23 3/21/24
1TRY in Million2TRY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Hospitals, Clinics & Primary Care Services

1st Jan change Capi.
NASMED ÖZEL SAGLIK HIZMETLERI TICARET ANONIM SIRKETI Stock Nasmed Özel Saglik Hizmetleri Ticaret Anonim Sirketi
+19.00% 89.94M
AIER EYE HOSPITAL GROUP CO., LTD. Stock Aier Eye Hospital Group Co., Ltd.
-22.00% 15.75B
BANGKOK DUSIT MEDICAL SERVICES Stock Bangkok Dusit Medical Services
+2.70% 12.47B
IHH HEALTHCARE Stock IHH Healthcare
+4.31% 11.73B
APOLLO HOSPITALS ENTERPRISE LIMITED Stock Apollo Hospitals Enterprise Limited
+4.12% 10.24B
ENCOMPASS HEALTH CORPORATION Stock Encompass Health Corporation
+26.63% 8.51B
RAMSAY HEALTH CARE LIMITED Stock Ramsay Health Care Limited
-5.87% 7.38B
THE ENSIGN GROUP, INC. Stock The Ensign Group, Inc.
+7.08% 6.78B
MOUWASAT MEDICAL SERVICES COMPANY Stock Mouwasat Medical Services Company
0.00% 6.13B
DALLAH HEALTHCARE COMPANY Stock Dallah Healthcare Company
-4.42% 4.28B
Hospitals, Clinics & Primary Care Services
  1. Stock Market
  2. Equities
  3. EGEPO Stock
  4. Financials Nasmed Özel Saglik Hizmetleri Ticaret Anonim Sirketi